PROM1 and colorectal cancer: Reportedly, CD133+ colorectal cancer cells had chemoresistance to 5-FU via survivin and ABCG2 expression [105], and ABCG2 knockdown inhibited the self-renewal capacity of these cells, and enhanced chemotherapy-induced apoptosis [106].